Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?
- PMID: 14722048
- DOI: 10.1200/JCO.2004.99.219
Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?
Comment on
-
Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.J Clin Oncol. 2003 Feb 15;21(4):631-7. doi: 10.1200/JCO.2003.06.158. J Clin Oncol. 2003. PMID: 12586799 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
